Cargando…

Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines

SIMPLE SUMMARY: Lung cancer is currently the second leading cause of cancer death worldwide. Cytokines are small proteins that carry messages between cells and are known to play an important role in the body’s response to inflammation and infection. Cytokines are important for immunity in lung cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Essogmo, Freddy Elad, Zhilenkova, Angelina V., Tchawe, Yvan Sinclair Ngaha, Owoicho, Abah Moses, Rusanov, Alexander S., Boroda, Alexander, Pirogova, Yuliya N., Sangadzhieva, Zaiana D., Sanikovich, Varvara D., Bagmet, Nikolay N., Sekacheva, Marina I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670546/
https://www.ncbi.nlm.nih.gov/pubmed/38001643
http://dx.doi.org/10.3390/cancers15225383
_version_ 1785149323608064000
author Essogmo, Freddy Elad
Zhilenkova, Angelina V.
Tchawe, Yvan Sinclair Ngaha
Owoicho, Abah Moses
Rusanov, Alexander S.
Boroda, Alexander
Pirogova, Yuliya N.
Sangadzhieva, Zaiana D.
Sanikovich, Varvara D.
Bagmet, Nikolay N.
Sekacheva, Marina I.
author_facet Essogmo, Freddy Elad
Zhilenkova, Angelina V.
Tchawe, Yvan Sinclair Ngaha
Owoicho, Abah Moses
Rusanov, Alexander S.
Boroda, Alexander
Pirogova, Yuliya N.
Sangadzhieva, Zaiana D.
Sanikovich, Varvara D.
Bagmet, Nikolay N.
Sekacheva, Marina I.
author_sort Essogmo, Freddy Elad
collection PubMed
description SIMPLE SUMMARY: Lung cancer is currently the second leading cause of cancer death worldwide. Cytokines are small proteins that carry messages between cells and are known to play an important role in the body’s response to inflammation and infection. Cytokines are important for immunity in lung cancer. The immune system relies heavily on cytokines which can also be produced in the laboratory for therapeutic use. Cytokine therapy helps the immune system to stop the growth or kill cancer cells including lung cancer cells. High doses of cytokines are required to induce a beneficial response in cancer patients, but doing so leads to many problems, including their short lifespan and toxicity. New technologies are being developed to help improve the targeting of cytokines and alter their side effects. ABSTRACT: Lung cancer is currently the second leading cause of cancer death worldwide. In recent years, checkpoint inhibitor immunotherapy (ICI) has emerged as a new treatment. A better understanding of the tumor microenvironment (TMJ) or the immune system surrounding the tumor is needed. Cytokines are small proteins that carry messages between cells and are known to play an important role in the body’s response to inflammation and infection. Cytokines are important for immunity in lung cancer. They promote tumor growth (oncogenic cytokines) or inhibit tumor growth (anti-tumour cytokines) by controlling signaling pathways for growth, proliferation, metastasis, and apoptosis. The immune system relies heavily on cytokines. They can also be produced in the laboratory for therapeutic use. Cytokine therapy helps the immune system to stop the growth or kill cancer cells. Interleukins and interferons are the two types of cytokines used to treat cancer. This article begins by addressing the role of the TMJ and its components in lung cancer. This review also highlights the functions of various cytokines such as interleukins (IL), transforming growth factor (TGF), and tumor necrosis factor (TNF).
format Online
Article
Text
id pubmed-10670546
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106705462023-11-13 Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines Essogmo, Freddy Elad Zhilenkova, Angelina V. Tchawe, Yvan Sinclair Ngaha Owoicho, Abah Moses Rusanov, Alexander S. Boroda, Alexander Pirogova, Yuliya N. Sangadzhieva, Zaiana D. Sanikovich, Varvara D. Bagmet, Nikolay N. Sekacheva, Marina I. Cancers (Basel) Review SIMPLE SUMMARY: Lung cancer is currently the second leading cause of cancer death worldwide. Cytokines are small proteins that carry messages between cells and are known to play an important role in the body’s response to inflammation and infection. Cytokines are important for immunity in lung cancer. The immune system relies heavily on cytokines which can also be produced in the laboratory for therapeutic use. Cytokine therapy helps the immune system to stop the growth or kill cancer cells including lung cancer cells. High doses of cytokines are required to induce a beneficial response in cancer patients, but doing so leads to many problems, including their short lifespan and toxicity. New technologies are being developed to help improve the targeting of cytokines and alter their side effects. ABSTRACT: Lung cancer is currently the second leading cause of cancer death worldwide. In recent years, checkpoint inhibitor immunotherapy (ICI) has emerged as a new treatment. A better understanding of the tumor microenvironment (TMJ) or the immune system surrounding the tumor is needed. Cytokines are small proteins that carry messages between cells and are known to play an important role in the body’s response to inflammation and infection. Cytokines are important for immunity in lung cancer. They promote tumor growth (oncogenic cytokines) or inhibit tumor growth (anti-tumour cytokines) by controlling signaling pathways for growth, proliferation, metastasis, and apoptosis. The immune system relies heavily on cytokines. They can also be produced in the laboratory for therapeutic use. Cytokine therapy helps the immune system to stop the growth or kill cancer cells. Interleukins and interferons are the two types of cytokines used to treat cancer. This article begins by addressing the role of the TMJ and its components in lung cancer. This review also highlights the functions of various cytokines such as interleukins (IL), transforming growth factor (TGF), and tumor necrosis factor (TNF). MDPI 2023-11-13 /pmc/articles/PMC10670546/ /pubmed/38001643 http://dx.doi.org/10.3390/cancers15225383 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Essogmo, Freddy Elad
Zhilenkova, Angelina V.
Tchawe, Yvan Sinclair Ngaha
Owoicho, Abah Moses
Rusanov, Alexander S.
Boroda, Alexander
Pirogova, Yuliya N.
Sangadzhieva, Zaiana D.
Sanikovich, Varvara D.
Bagmet, Nikolay N.
Sekacheva, Marina I.
Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines
title Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines
title_full Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines
title_fullStr Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines
title_full_unstemmed Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines
title_short Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines
title_sort cytokine profile in lung cancer patients: anti-tumor and oncogenic cytokines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670546/
https://www.ncbi.nlm.nih.gov/pubmed/38001643
http://dx.doi.org/10.3390/cancers15225383
work_keys_str_mv AT essogmofreddyelad cytokineprofileinlungcancerpatientsantitumorandoncogeniccytokines
AT zhilenkovaangelinav cytokineprofileinlungcancerpatientsantitumorandoncogeniccytokines
AT tchaweyvansinclairngaha cytokineprofileinlungcancerpatientsantitumorandoncogeniccytokines
AT owoichoabahmoses cytokineprofileinlungcancerpatientsantitumorandoncogeniccytokines
AT rusanovalexanders cytokineprofileinlungcancerpatientsantitumorandoncogeniccytokines
AT borodaalexander cytokineprofileinlungcancerpatientsantitumorandoncogeniccytokines
AT pirogovayuliyan cytokineprofileinlungcancerpatientsantitumorandoncogeniccytokines
AT sangadzhievazaianad cytokineprofileinlungcancerpatientsantitumorandoncogeniccytokines
AT sanikovichvarvarad cytokineprofileinlungcancerpatientsantitumorandoncogeniccytokines
AT bagmetnikolayn cytokineprofileinlungcancerpatientsantitumorandoncogeniccytokines
AT sekachevamarinai cytokineprofileinlungcancerpatientsantitumorandoncogeniccytokines